Current decision support tools fail to agree or predict therapeutic decisions in a single cohort of unruptured intracranial aneurysms.

The models studied failed to agree with the consensus view of multi-disciplinary team in a major neurovascular centre. We conclude that decision support tools such as the UIATS and PHASES scores should not be blindly introduced in respective institutions without prior internal validation, as they may not represent the local reality.